BCL2A1 and neoplasm: BC transfection was found to sensitize cells to gemcitabine by suppressing NF-κB activity and Bfl-1; and moreover co-treatment by BC transfection and gemcitabine chemotherapy showed a strong anti-tumor effect in vivo.